Anemia and Erythrocytes: Behavior and Prevalence 1 Year After Kidney Transplant.

Autor: Rosales Morales KB; Renal Transplant Unit, National Healthcare Medical Center 'Siglo XXI,' IMSS, México City, Mexico., Pérez RE; Renal Transplant Unit, National Healthcare Medical Center 'Siglo XXI,' IMSS, México City, Mexico., Cancino López JD; Renal Transplant Unit, National Healthcare Medical Center 'Siglo XXI,' IMSS, México City, Mexico., Díaz ER; Renal Transplant Unit, National Healthcare Medical Center 'Siglo XXI,' IMSS, México City, Mexico., Chacón Pérez MJ; Renal Transplant Unit, National Healthcare Medical Center 'Siglo XXI,' IMSS, México City, Mexico., Zavalza Camberos PA; Renal Transplant Unit, National Healthcare Medical Center 'Siglo XXI,' IMSS, México City, Mexico., Cheng MDCA; Renal Transplant Unit, National Healthcare Medical Center 'Siglo XXI,' IMSS, México City, Mexico., Cedillo Galindo HA; Renal Transplant Unit, National Healthcare Medical Center 'Siglo XXI,' IMSS, México City, Mexico., Morinelli Astorquizaga MA; Renal Transplant Unit, National Healthcare Medical Center 'Siglo XXI,' IMSS, México City, Mexico., Trejo Villeda LEM; Kidney Diseases Medical Research Unit, National Healthcare Medical Center 'Siglo XXI,' IMSS, México City, México., Sierra RP; Kidney Diseases Medical Research Unit, National Healthcare Medical Center 'Siglo XXI,' IMSS, México City, México., Hernández Rivera JCH; Kidney Diseases Medical Research Unit, National Healthcare Medical Center 'Siglo XXI,' IMSS, México City, México. Electronic address: juancarloshhernandezrivera@hotmail.com.
Jazyk: angličtina
Zdroj: Transplantation proceedings [Transplant Proc] 2020 May; Vol. 52 (4), pp. 1169-1172. Date of Electronic Publication: 2020 Mar 10.
DOI: 10.1016/j.transproceed.2020.01.053
Abstrakt: Introduction: Renal transplantation presents multiple complications after its completion, some of them related to the behavior of hemoglobin levels. The objective of this study is to determine the behavior and prevalence of anemia and erythrocytosis in the first year after renal transplantation.
Material and Methods: A retrospective, observational study was conducted of a cohort of patients of the 21st Century National Medical Center in Mexico of transplants performed from January 1, 2013 to December 31, 2017. A total of 649 met the inclusion criteria. Pre-transplant hemoglobin (Hb) levels were determined, as well as levels 1 month, 3, 6, 9, and 12 months after transplantation, and the prevalence of anemia and erythrocytosis was determined in each month. Descriptive analysis was performed with measures of central tendency and measures of dispersion. The statistical program SPSS version 25 was used.
Results: The mean pre-transplant Hb was 10.69 g/dL (standard deviation [SD] 2.04). One year after the renal transplant, Hb averaged 14.45 g/dL (SD 2.30), which meant an increase over the first year after renal transplantation of 3.76 g/dL. Pre-transplant anemia occurred in 73.1% of patients, and erythrocytosis in 0.1%; 12.9% of patients and 5.9% in erythrocytosis continued with anemia for a year.
Conclusions: Renal transplantation allows Hb levels to recover in a multifactorial way; however, the persistence of anemia and erythrocytes creates a study challenge in any transplant unit, due to their prevalence of 12.9 and 5.9% respectively.
(Copyright © 2020 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE